Immunoassay labels based on chemiluminescence and bioluminescence.

Reagents required for reactions that produce chemiluminescence (CL) or bioluminescence (BL) may be coupled to antibodies or antigens and used as labels for immunoassay. Because methods based on CL and BL have very low detection limits, they have the potential to replace assays that currently employ radioisotopes as labels. The feasibility of several BL and CL labels has been demonstrated. To date, isoluminol derivatives have been most widely studied. Several steroid assays involving isoluminol labels have been reported, and labelled compound has been detected at levels approaching 10(17) moles. Acridinium ester-labelled compounds have also been detected at this level. In addition to systems in which the label is a reactant required for light, CL and BL can be used to analyze the amount of product generated by enzyme labels. This approach has also yielded very low detection limits. Systems have been developed using enzyme labels that catalyze formation of ATP which is then assayed by the firefly reaction or that catalyze formation of peroxide which is determined by either luminol or peroxyoxalate CL.

[1]  A. Campbell,et al.  A new chemiluminescent label for use in immunoassay , 1982 .

[2]  M. Deluca,et al.  A bioluminescent immunoassay for methotrexate at the subpicomole level. , 1980, Biochemical and biophysical research communications.

[3]  H. R. Schroeder,et al.  Immunochemiluminometric assay for hepatitis B surface antigen. , 1981, Clinical chemistry.

[4]  J. B. Kim,et al.  An assay for urinary estriol-16α-glucuronide based on antibody-enhanced chemiluminescence , 1980, Steroids.

[5]  R. Boguslaski,et al.  Competitive protein binding assay for biotin monitored by chemiluminescence. , 1976, Analytical chemistry.

[6]  S. Avrameas,et al.  Light emission techniques for the microestimation of femtogram levels of peroxidase. Application to peroxidase (and other enzymes)-coupled antibody-cell antigen interactions. , 1977, Analytical biochemistry.

[7]  L. Meurling,et al.  The measurement of serum cortisol by a solid-phase chemiluminescence immunoassay. , 1982, Journal of steroid biochemistry.

[8]  H. R. Schroeder.  [23] Chemiluminescence immunoassay for serum thyroxine , 1982 .

[9]  B. Velan,et al.  Chemiluminescence immunoassay: a new sensitive method for determination of antigens. , 1978, Immunochemistry.

[10]  H. R. Schroeder,et al.  Chemiluminescence yields and detection limits of some isoluminol derivatives in various oxidation systems , 1978 .

[11]  R. Boguslaski,et al.  [12] ATP-Labeled ligands and firefly luciferase for monitoring specific protein-binding reactions , 1978 .

[12]  L. Kricka,et al.  Analytical luminescence: its potential in the clinical laboratory. , 1979, Clinical chemistry.

[13]  M. M. Rauhut.  Chemiluminescence from concerted peroxide decomposition reactions , 1969 .

[14]  J. B. Kim,et al.  Development of a solid-phase chemiluminescence immunoassay for plasma progesterone , 1981, Steroids.

[15]  W. Vann,et al.  A luminol-assisted competitive binding immunoassay of human immunoglobulin G. , 1981, Methods in enzymology.

[16]  R. Boguslaski,et al.  Specific binding reactions monitored with ligand-cofactor conjugates and bacterial luciferase. , 1976, Analytical biochemistry.

[17]  J. B. Kim,et al.  Measurement of plasma estradiol-17 beta by solid-phase chemiluminescence immunoassay. , 1982, Clinical chemistry.

[18]  L. Villerius,et al.  Chemiluminescence-linked immunoassay. , 1978, Journal of immunological methods.

[19]  A. Campbell,et al.  Chemiluminescence energy transfer: a new technique applicable to the study of ligand--ligand interactions in living systems. , 1983, Analytical biochemistry.

[20]  R. Boguslaski,et al.  Immunoassay for serum thyroxine monitored by chemiluminescence. , 1979, Journal of immunological methods.

[21]  W. Seitz,et al.  Recent advances in bioluminescence and chemiluminescence assay. , 1976, Methods of biochemical analysis.

[22]  J. B. Kim,et al.  Use of monoclonal antibodies to pregnanediol-3α-glucuronide for the development of a solid phase chemiluminescence immunoassay , 1981, Steroids.

[23]  J. B. Kim,et al.  An assay procedure for plasma progesterone based on antibody‐enhanced chemiluminescence , 1979, FEBS letters.

[24]  J. S. Woodhead,et al.  A stable chemiluminescent-labelled antibody for immunological assays , 1979, Nature.

[25]  A. Thore,et al.  Luminescence immunoassay (LIA): a solid-phase immunoassay monitored by chemiluminescence. , 1979, Journal of immunological methods.

[26]  F. Gorus,et al.  Applications of bio- and chemiluminescence in the clinical laboratory. , 1979, Clinical chemistry.

[27]  A. Tsuji,et al.  Chemiluminescence enzyme immunoassay of 17 alpha-hydroxyprogesterone using glucose oxidase and bis(2,4,6-trichlorophenyl) oxalate - fluorescent dye system. , 1982, Chemical & pharmaceutical bulletin.

[28]  J. B. Kim,et al.  Monitoring ovarian function by a solid-phase chemiluminescence immunoassay. , 1982, Acta endocrinologica.

[29]  S. Iwasa,et al.  Chemiluminescence-linked immunoassay for detection of mumps virus antibodies , 1980, Journal of clinical microbiology.

[30]  W. Seitz,et al.  Chemiluminescence and Bioluminescence Analysis: Fundamentals and Biomedical Applications , 1981 .

[31]  R. Boguslaski,et al.  Specific protein-binding reactions monitored with ligand--ATPase conjugates and firefly luciferase. , 1976, Analytical biochemistry.

[32]  James N. Miller,et al.  Flow injection analysis with chemiluminescence detection in the determination of fluorescein- and fluorescamine-labelled species , 1983 .